Japan To Approve Remote Care

29 September 1996

The Japanese Ministry of Health and Welfare is preparing to give its approval to the use of remote medical examination and treatment, according to a report in the Japan Times. At present, the Medical Service Law does not permit medical treatment or drug prescribing without a face-to-face consultation, but the MHW is said to interpret this legislation as stating that face-to-face diagnosis is not essential.

A team of research workers at the Ministry is currently testing electronic communications and equipment used in remote medical care, and will present a report by next March. After that, the MHW will notify the prefectural governments and medical organizations of its new interpretation of the Medical Services Law, say the reports.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight